Brian Mann
-
Companies that sold or distributed opioid medications face huge legal, financial and public relations peril. Critics say shareholders, not CEOs, will pay the price.
-
Companies that sold or distributed opioid medications face huge legal, financial and public relations peril. Critics say shareholders, not CEOs, will pay the price.
-
Under a bankruptcy plan filed late Monday, the OxyContin maker would pay $500 million up front, promising billions in future payments. Twenty-four states rejected the proposal.
-
The CDC says hospitals saw a lot more emergency cases involving drug overdoses, as well as mental health crises and suicide attempts. Many emergency departments weren't ready.
-
Black Americans with addiction face "pervasive and continuing systemic racism" and often struggle to gain access to treatments that prevent fatal overdoses.
-
The state opened a mass vaccination site at Yankee Stadium in the Bronx on Friday and is working with Black pastors to overcome worries about vaccine safety.
-
McKinsey is the latest major American corporation to face legal, financial and public relations peril stemming from its role in the nation's deadly opioid epidemic.
-
President Biden hasn't named a permanent drug czar but White House officials say they will work to curb overdose deaths in the first 100 days.
-
A report issued by Attorney General Letitia James concluded the New York State Department of Health numbers fell short by "as much as 50%."
-
More than 200 Americans are dying from drug overdoses daily. Now the Biden administration faces criticism for reportedly delaying a Trump administration policy widely seen as a way to help save lives.